Is Insulin isophane registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Insulin isophane, including HUMULIN 70-30 100U-ML (100 IU/ml, Suspension for injection, SAR 53.55); HUMULIN-N-NPH 100 U-ML (100 IU/ml, Suspension for injection, SAR 53.55).

Active substance

Insulin isophane

SFDA 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
HUMULIN 70-30 100U-ML	100 IU/ml	Suspension for injection · Subcutaneous use	1 Vial	SAR 53.55	Biological · Prescription	Eli Lilly and Company	Valid
HUMULIN-N-NPH 100 U-ML	100 IU/ml	Suspension for injection · Subcutaneous use	1 Vial	SAR 53.55	Biological · Prescription	Eli Lilly and Company	Valid
INSULATARD HM 100 I.U NOVOLET	100 IU/ml	Suspension for injection · Subcutaneous use	5 Cartridge	SAR 166.35	Biological · Prescription	NOVO NORDISK	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

DIABETES MELLITUS TYPE 1; DIABETES MELLITUS TYPE 2

Combinations containing Insulin isophane

Insulin human + insulin isophane

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.